Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A safety and tolerability study of NC318 in advanced or metastatic solid tumors completed Phase 1/2 with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Phase II Study of GTx024 in Women With Metastatic Breast Cancer [Phase 2]
Phase II study of GTx024 in women with metastatic breast cancer was terminated; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial update evaluating combination chemotherapy with trastuzumab in metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer [Phase 3]
Phase 3 trial update evaluating neoadjuvant nab-paclitaxel in HER2-negative high-risk breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer. [Phase 2]
Phase 2 trial update for MCLA-128 in combination with trastuzumab/chemotherapy in HER2-positive breast cancer and with endocrine therapy in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Sorafenib in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial of sorafenib in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer [Phase 2]
Phase II trial evaluating pembrolizumab in combination with nab-paclitaxel for HER-2 negative metastatic breast cancer; results have been po…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 [Phase 3]
Phase 3 neoadjuvant trial update in triple-negative breast cancer evaluating anti-PD-L1 therapy combined with standard treatment.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System [NA]
A completed clinical trial update assessing care coordination for complex cancer survivors within an integrated safety net system; results p…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage [Phase 4]
Phase 4 trial assessing Hemopatch® effectiveness in reducing post-surgical serous drainage in breast cancer patients undergoing axillary lym…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer [Phase 3]
Phase 3 neoadjuvant trial update for HER2-positive early high-risk and locally advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark
Retrospective non-interventional study of HR+/HER2- locally advanced or metastatic breast cancer patients treated with palbociclib in Denmar…
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Altering Lipids for Tolerance of Aromatase Inhibitor Therapy [Phase 2]
Phase 2 clinical trial updating on altering lipids to improve tolerance of aromatase inhibitor therapy in breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients [Phase 3]
A Phase 3 trial evaluating whether rosuvastatin can protect against chemotherapy-induced cardiotoxicity in HER2-positive breast cancer patie…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients [Phase 1, Phase 2]
A clinical trial update for Ficus septica leaf fraction used as a complementary therapy in stage IV breast cancer (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC). [Phase 4]
Phase 4 trial exploring the efficacy and safety of pirotinib (pyrotinib) plus trastuzumab and taxanes in trastuzumab-treated HER2-positive a…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Exercise Program in Cancer and Cognition [NA]
A completed clinical trial evaluating an exercise program’s effects on cognition in individuals with breast cancer; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Stockholm Mammography Risk Stratified Trial [Phase 3]
Phase 3 clinical trial update for a breast cancer study at Karolinska Institutet; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: TOPS for African American Breast Cancer Survivors [NA]
A completed clinical trial evaluating the TOPS program for feasibility and acceptability among African American breast cancer survivors, wit…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial update of palbociclib in molecularly characterized ER-positive/HER2-negative metastatic breast cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial [Phase 3]
Phase 3 trial evaluating disitamab vedotin plus pyrotinib versus THP in first-line HER2-positive metastatic breast cancer is currently recru…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 trial update investigating dalpiciclib with fulvestrant, trastuzumab, and pertuzumab in HR-positive, HER2-positive metastati…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: MEtronomic TrEatment Option in Advanced bReast cAncer [Phase 2]
Phase 2 clinical trial update for a treatment option in advanced breast cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating enobosarm in combination with abemaciclib for ER+HER2- metastatic breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for GQ1001 combined with Pyrotinib in HER2-positive metastatic breast cancer across Phase 1 and Phase 2.